|By PR Newswire||
|September 22, 2016 03:31 PM EDT|
NEW YORK, Sept. 22, 2016 /PRNewswire/ -- Truveris, a leading provider of solutions across the prescription drug ecosystem, today announced the appointment of Faisal Mushtaq as the chief executive officer. Mr. Mushtaq brings to Truveris deep experience in health information technology and extensive entrepreneurial expertise.
Truveris works with Fortune 500 employers, global pharmaceutical brands and benefits consulting organizations to help manage pharmacy benefits and improve consumer engagement. Truveris' deep understanding of the complex prescription drug ecosystem, which includes pharmaceutical manufacturers, prescription benefit managers (PBMs), pharmacies, payers, consumers, and providers, enables the company to provide unparalleled insights to its customers and partners. With consistent, exponential revenue growth over the last three years, Truveris continues to strengthen its infrastructure and rapidly expand its product and customer footprint.
"Mr. Mushtaq is a seasoned digital health executive with the experience and the acumen necessary to lead Truveris," said Stephen Bloch, MD, general partner at Canaan Partners and a member of Truveris' board. "Faisal will build on Truveris' mission to simplify and make transparent how we each pay for prescriptions. As a physician, I share Faisal's vision of making medications accessible and affordable for all."
Truveris' knowledge of drug pricing forms the foundation of its monthly National Drug Index (NDI) which calculates the average price for all prescription drugs, weighted by utilization. The latest NDI and accompanying analysis shows that the average price of prescription drugs rose 7.70% over the last 12 months and may be leading to an increase in prescription abandonment rates. When patients don't fill their prescriptions, complications and ER visits increase, leading to an overall increase in the healthcare spending.
"The system of determining the price paid for a prescription drug is opaque and difficult to understand," said Mr. Mushtaq. "This leads to inefficiencies and inequities in the marketplace, affecting consumers, payers, pharmaceutical companies and the pharmacy benefits managers. Truveris has emerged as a proven innovator, and I look forward to continuing the development of solutions that address the most complex problems to achieve improved clinical outcomes and financial results."
Prior to joining Truveris, Mr. Mushtaq served as senior vice president and general manager, payer life sciences for Allscripts. He led Allscripts' fastest growing business, building innovative solutions for payers, pharmaceutical manufacturers, clinical research organizations and providers. Previously, Mr. Mushtaq served in several executive leadership roles at Misys, which was acquired by Allscripts in 2008. Mr. Mushtaq earned a bachelor of science in electrical engineering and computer science from the University of Wisconsin-Madison. He is also a graduate of the Advanced Management Program at Harvard Business School.
Founded in 2009, Truveris brings transparency to the prescription drug ecosystem through data-driven innovation. Truveris' platform offers customers – from the individual patient to employers to pharmacy benefits stakeholders and manufacturers – the data and insights they need to effectively and efficiently manage the rising costs and market access strategies. Based in New York City, Truveris is funded by Canaan Partners, New Leaf Venture Partners, Tribeca Venture Partners, New Atlantic Ventures and First Round Capital. For more information, visit truveris.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/truveris-strengthens-leadership-team-with-appointment-of-faisal-mushtaq-as-chief-executive-officer-300332830.html
Sep. 26, 2016 04:30 PM EDT Reads: 1,614
Sep. 26, 2016 04:30 PM EDT Reads: 3,326
Sep. 26, 2016 04:30 PM EDT Reads: 2,065
Sep. 26, 2016 04:15 PM EDT Reads: 1,016
Sep. 26, 2016 04:00 PM EDT Reads: 2,507
Sep. 26, 2016 04:00 PM EDT Reads: 2,815
Sep. 26, 2016 03:45 PM EDT Reads: 2,894
Sep. 26, 2016 03:30 PM EDT Reads: 1,554
Sep. 26, 2016 03:00 PM EDT Reads: 1,549
Sep. 26, 2016 02:45 PM EDT Reads: 2,603
Sep. 26, 2016 02:30 PM EDT Reads: 2,538
Sep. 26, 2016 02:15 PM EDT Reads: 2,096
Sep. 26, 2016 02:00 PM EDT Reads: 1,716
There is little doubt that Big Data solutions will have an increasing role in the Enterprise IT mainstream over time. Big Data at Cloud Expo - to be held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA - has announced its Call for Papers is open. Cloud computing is being adopted in one form or another by 94% of enterprises today. Tens of billions of new devices are being connected to The Internet of Things. And Big Data is driving this bus. An exponential increase is...
Sep. 26, 2016 01:45 PM EDT Reads: 2,570
Digital innovation is the next big wave of business transformation based on digital technologies of which IoT and Big Data are key components, For example: Business boundary innovation is a challenge to excavate third-party business value using IoT and BigData, like Nest Business structure innovation may propose re-building business structure from scratch, as Uber does in the taxicab industry The social model innovation is also a big challenge to the new social architecture with the design fr...
Sep. 26, 2016 01:30 PM EDT Reads: 1,168